» Articles » PMID: 27783501

Biomimetic, Osteoconductive Non-mulberry Silk Fiber Reinforced Tricomposite Scaffolds for Bone Tissue Engineering

Overview
Date 2016 Nov 5
PMID 27783501
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Composite biomaterials as artificial bone graft materials are pushing the present frontiers of bioengineering. In this study, a biomimetic, osteoconductive tricomposite scaffold made of hydroxyapatite (HA) embedded in non-mulberry Antheraea assama (A. assama) silk fibroin fibers and its fibroin solution is explored for its osteogenic potential. Scaffolds were physico-chemically characterized for morphology, porosity, secondary structure conformation, water retention ability, biodegradability, and mechanical property. The results revealed a ∼5-fold increase in scaffold compressive modulus on addition of HA and silk fibers to liquid silk as compared to pure silk scaffolds while maintaining high scaffold porosity (∼90%) with slower degradation rates. X-ray diffraction (XRD) results confirmed deposition of HA crystals on composite scaffolds. Furthermore, the crystallite size of HA within scaffolds was strongly regulated by the intrinsic physical cues of silk fibroin. Fourier transform infrared (FTIR) spectroscopy studies indicated strong interactions between HA and silk fibroin. The fabricated tricomposite scaffolds supported enhanced cellular viability and function (ALP activity) for both MG63 osteosarcoma and human bone marrow stem cells (hBMSCs) as compared to pure silk scaffolds without fiber or HA addition. In addition, higher expression of osteogenic gene markers such as collagen I (Col-I), osteocalcin (OCN), osteopontin (OPN), and bone sialoprotein (BSP) further substantiated the applicability of HA composite silk scaffolds for bone related applications. Immunostaining studies confirmed localization of Col-I and BSP and were in agreement with real-time gene expression results. These findings demonstrate the osteogenic potential of developed biodegradable tricomposite scaffolds with the added advantage of the affordability of its components as bone graft substitute materials.

Citing Articles

Engineering biomimetic silk fibroin hydrogel scaffolds with "organic-inorganic assembly" strategy for rapid bone regeneration.

Liang R, Li R, Mo W, Zhang X, Ye J, Xie C Bioact Mater. 2024; 40:541-556.

PMID: 39055734 PMC: 11269296. DOI: 10.1016/j.bioactmat.2024.06.024.


Biomimetic fabrication of sr-silk fibroin co-assembly hydroxyapatite based microspheres with angiogenic and osteogenic properties for bone tissue engineering.

Liu Y, Shi C, Ming P, Yuan L, Jiang X, Jiang M Mater Today Bio. 2024; 25:101011.

PMID: 38445010 PMC: 10912917. DOI: 10.1016/j.mtbio.2024.101011.


Kaempferol-loaded bioactive glass-based scaffold for bone tissue engineering: in vitro and in vivo evaluation.

Ranjbar F, Farzad-Mohajeri S, Samani S, Saremi J, Khademi R, Dehghan M Sci Rep. 2023; 13(1):12375.

PMID: 37524784 PMC: 10390521. DOI: 10.1038/s41598-023-39505-8.


Silk fibroin scaffolds: A promising candidate for bone regeneration.

Wu H, Lin K, Zhao C, Wang X Front Bioeng Biotechnol. 2022; 10:1054379.

PMID: 36507269 PMC: 9732393. DOI: 10.3389/fbioe.2022.1054379.


Application of vancomycin-impregnated calcium sulfate hemihydrate/nanohydroxyapatite/carboxymethyl chitosan injectable hydrogels combined with BMSC sheets for the treatment of infected bone defects in a rabbit model.

Wang Y, Zhao Z, Liu S, Luo W, Wang G, Zhu Z BMC Musculoskelet Disord. 2022; 23(1):557.

PMID: 35681160 PMC: 9185966. DOI: 10.1186/s12891-022-05499-z.